Zipalertinib plus chemo shows survival benefit in lung cancer trial

Investing.com•Sun, Sep 13, 2026, 11:20 PM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Investing.com](https://www.investing.com/news/company-news/zipalertinib-plus-chemo-shows-survival-benefit-in-lung-cancer-trial-93CH-4898765)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Investing.com ↗

#finance #zipalertinib #plus #chemo #shows #survival #benefit #lung #cancer

More Headlines

FinanceHacker News• 10m ago

Financial literacy and investment: empirical study from Palestine Stock Exchange

1 points, 0 comments on Hacker News

FinanceBloomberg Markets• 11m ago

Anthropic’s AI Warning Seen as Setback for Chip Stocks

AI executives' calls to slow development of the technology are likely to weigh on chipmaker and supply-chain stocks in the near term. Bloomberg's Sunny Bangia and Anthony Stephens break down the news.

FinanceSeeking Alpha• 22m ago

Columbia Strategic Income Fund Q2 2026 Commentary

Developing story — details emerging. Check the source link for the latest updates.

FinanceBloomberg Markets• 24m ago

Gold Edges Lower as Hot US Inflation Bolsters Fed Rate-Hike Bets

Gold edged lower, after hotter-than-expected US inflation data raised prospects that the Federal Reserve will hike interest rates later this week.

FinanceInvesting.com• 27m ago

Dollar steady, yen near 7-month high ahead of Fed, BOJ meetings

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 31m ago

U.S. stock futures slide on calls to slow AI development, M.East escalation

Developing story — details emerging. Check the source link for the latest updates.